RUO
Background
Respiratory tract infection (RTI) is one of the most common diseases in humans, which can occur in any gender, age group and region. Most respiratory tract infections are caused by viruses, chlamydia or mycoplasma. These pathogens are diverse, and the clinical symptoms and signs they cause are relatively similar. Their clinical manifestations mainly include rhinitis, pharyngitis, laryngitis, tonsillitis and other symptoms. In severe cases, they can cause tracheitis, bronchitis, pneumonia, etc. However, infections caused by different pathogens vary in terms of treatment methods, curative effects and disease courses.
This kit is intended for in vitro qualitative detection of respiratory pathogens in human specimens including swabs (oropharyngeal and nasopharyngeal), nasopharyngeal aspirates, sputum, and bronchoalveolar lavage fluid. The Panel includes SARS-CoV-2, influenza A viruses (H1N1, H1N1-09, H3N2, H5N1, H7N9), influenza B virus, respiratory syncytial virus, adenovirus, parainfluenza virus types 1, 2, 3, and 4, respiratory enteroviruses (enterovirus/rhinovirus); human metapneumovirus, coronaviruses 229E, OC43, NL63, and HKU1; bocavirus; Mycoplasma pneumoniae; Chlamydia pneumoniae, Bordetella pertussis, Legionella pneumophila, Haemophilus influenzae, Streptococcus pneumoniae and Bordetella parapertussis. Influenza A virus subtyping is not performed.
Results are for research use only and must not be used for clinical diagnosis.
Use only with the company's Nucleic Acid Chip Analyzer (BHF-VI).
